Introduction and objectives:Although female gender has been implicated as a risk factor for AAA repair, the etiologies for this gender difference remains ill defined. We prospectively analyzed variables that might impact the aneurysm-related morbidity and mortality in women.Methods: From 2002 to 2009, 2631 consecutive AAA patients undergoing open surgical and endovascular aneurysm repair (EVAR) were entered into a registry based on female (n ϭ 636, 24%) vs male (n ϭ 1995, 76%) gender. Data were prospectively collected and all variables analyzed.Results: Of the 2631 AAA patients, both genders were comparable with respect to demographics with one exception: women had a higher incidence of COPD (24% vs 15%, P Ͻ .05). A higher percentage of women presented with AAA rupture (14% vs 8%, P Ͻ .05). Compared with men, women undergoing EVAR had a significant higher mortality (elective EVAR: 3.2% vs 0.9%; emergent EVAR: 27.3% vs 17.2%; all EVAR: 5.3% vs 1.9%, P Ͻ .05), arterial rupture (4.1% vs 1.2%, P Ͻ .05), postoperative bleeding (4.9% vs 2.9%, P Ͻ .05), lower extremity ischemic complications (3.5% vs 0.6%, P Ͻ .05), ischemic colitis (4.1% vs 1.2%, P Ͻ .05), Palmaz stent placement for type I endoleak (16.3% vs 7.2%, P Ͻ .05), and mean hospital length of stay (4.1 vs 1.8 days, P Ͻ .05). These gender differences were not significant in the elective and emergent open surgical groups. At a mean follow-up of 26 months, there were no gender differences in survival, secondary interventions, or freedom from aneurysm rupture.Conclusions: A higher percentage of women present with aneurysm rupture. When treated by endovascular means, in comparison with men, women have higher procedurally related morbidity of intraoperative arterial rupture, postoperative bleeding, lower extremity ischemic complications, ischemic colitis, and type I endoleaks requiring adjunctive procedures. These findings suggest the need for improvements in stent graft design and EVAR procedures that are better suited for women.